DeltaPoint, Inc., is an early stage medical technology company based in Portland, Oregon, developing a non-invasive method for diagnosing and monitoring cancer.
DeltaPoint is commercializing a patent-pending cancer diagnostic imaging biomarker - by analyzing dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) data. The biomarker is the first to reliably and non-invasively discriminate benign from malignant tumors.
The company is initially focused on the breast cancer market.
|
|
|
|
|
11-50 employees
View all DeltaPoint, Inc. employees
|
|
|
Biotechnology Research
|
|
|
12665 NW Majestic Sequoia Way, Portland, OR 97229, US
|
|
|
2009
|
|
|
Cancer Diagnostic Medical Imaging Biomarker
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.